Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient

Liver Transpl. 2018 Jan;24(1):140-143. doi: 10.1002/lt.24838.

Authors

Behnam Saberi¹, James P Hamilton¹, Christine M Durand², Zhiping Li¹, Benjamin Philosophe³, Andrew M Cameron³, Mark S Sulkowski², Ahmet Gurakar¹

Affiliations

¹ Division of Gastroenterology and Hepatology, The Johns Hopkins University School of Medicine, Baltimore, MD.
² Division of Infectious Disease, The Johns Hopkins University, School of Medicine, Baltimore, MD.
³ Department of Transplant Surgery, The Johns Hopkins University, School of Medicine, Baltimore, MD.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Allografts / virology
Antiviral Agents / therapeutic use
Drug Combinations
End Stage Liver Disease / drug therapy
End Stage Liver Disease / surgery*
End Stage Liver Disease / virology
Female
Hepacivirus / drug effects
Hepacivirus / genetics
Hepacivirus / isolation & purification*
Hepatitis C / drug therapy
Hepatitis C / transmission*
Hepatitis C / virology
Humans
Liver / virology
Liver Transplantation / methods*
Male
Middle Aged
Postoperative Care / methods
RNA, Viral / isolation & purification*
Recurrence
Severity of Illness Index
Sustained Virologic Response
Tissue Donors

Substances

Antiviral Agents
Drug Combinations
RNA, Viral

Grants and funding

P30 DK089502/DK/NIDDK NIH HHS/United States